Jagadishwar Pharmaceutical Works achieved a standalone net profit of ₹0.06 crore in the quarter ended June 2026, marking a significant turnaround from the net loss of ₹0.02 crore recorded during the corresponding quarter of the previous year. According to reports from Business Standard, this represents a complete reversal of the company's financial performance compared to June 2025.
The company reported zero sales for both the quarter ended June 2026 and the corresponding quarter of the previous year. As reported by Business Standard, this indicates that the profitability improvement was achieved despite the absence of any revenue generation during the quarter.
The June 2026 quarter results show a profit of ₹0.06 crore compared to a loss of ₹0.02 crore in the same quarter of the previous year. According to Business Standard, this represents a profit improvement of ₹0.08 crore year-over-year, demonstrating the company's ability to achieve positive net results despite challenging market conditions.
